162 related articles for article (PubMed ID: 14645245)
1. Fibronectin binds insulin-like growth factor-binding protein 5 and abolishes Its ligand-dependent action on cell migration.
Xu Q; Yan B; Li S; Duan C
J Biol Chem; 2004 Feb; 279(6):4269-77. PubMed ID: 14645245
[TBL] [Abstract][Full Text] [Related]
2. Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells.
Xu Q; Li S; Zhao Y; Maures TJ; Yin P; Duan C
Circ Res; 2004 Mar; 94(5):E46-54. PubMed ID: 15001525
[TBL] [Abstract][Full Text] [Related]
3. Importin α-importin β complex mediated nuclear translocation of insulin-like growth factor binding protein-5.
Sun M; Long J; Yi Y; Xia W
Endocr J; 2017 Oct; 64(10):963-975. PubMed ID: 28835592
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma.
Gui Y; Murphy LJ
J Clin Endocrinol Metab; 2001 May; 86(5):2104-10. PubMed ID: 11344214
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2).
Amaar YG; Thompson GR; Linkhart TA; Chen ST; Baylink DJ; Mohan S
J Biol Chem; 2002 Apr; 277(14):12053-60. PubMed ID: 11821401
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin fragments upregulate insulin-like growth factor binding proteins in chondrocytes.
Purple CR; Untermann TG; Pichika R; Homandberg GA
Osteoarthritis Cartilage; 2002 Sep; 10(9):734-46. PubMed ID: 12202126
[TBL] [Abstract][Full Text] [Related]
7. IGFBP-3 and IGFBP-5 associate with the cell binding domain (CBD) of fibronectin.
Beattie J; Kreiner M; Allan GJ; Flint DJ; Domingues D; van der Walle CF
Biochem Biophys Res Commun; 2009 Apr; 381(4):572-6. PubMed ID: 19236847
[TBL] [Abstract][Full Text] [Related]
8. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
Kim SK; Kwon JY; Nam TJ
Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
[TBL] [Abstract][Full Text] [Related]
10. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.
Hsieh T; Gordon RE; Clemmons DR; Busby WH; Duan C
J Biol Chem; 2003 Oct; 278(44):42886-92. PubMed ID: 12917428
[TBL] [Abstract][Full Text] [Related]
11. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration.
Hyde C; Hollier B; Anderson A; Harkin D; Upton Z
J Invest Dermatol; 2004 May; 122(5):1198-206. PubMed ID: 15140223
[TBL] [Abstract][Full Text] [Related]
14. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin.
Arai T; Clarke J; Parker A; Busby W; Nam T; Clemmons DR
J Biol Chem; 1996 Mar; 271(11):6099-106. PubMed ID: 8626396
[TBL] [Abstract][Full Text] [Related]
15. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes.
Sunic D; McNeil JD; Rayner TE; Andress DL; Belford DA
Endocrinology; 1998 May; 139(5):2356-62. PubMed ID: 9564845
[TBL] [Abstract][Full Text] [Related]
16. Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation.
Yan X; Forbes BE; McNeil KA; Baxter RC; Firth SM
J Biol Chem; 2004 Dec; 279(51):53232-40. PubMed ID: 15485880
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I.
Jones JI; Gockerman A; Busby WH; Camacho-Hubner C; Clemmons DR
J Cell Biol; 1993 May; 121(3):679-87. PubMed ID: 7683690
[TBL] [Abstract][Full Text] [Related]
18. Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions.
Kalus W; Zweckstetter M; Renner C; Sanchez Y; Georgescu J; Grol M; Demuth D; Schumacher R; Dony C; Lang K; Holak TA
EMBO J; 1998 Nov; 17(22):6558-72. PubMed ID: 9822601
[TBL] [Abstract][Full Text] [Related]
19. Type Ialpha collagen is an IGFBP-3 binding protein.
Liu B; Weinzimer SA; Gibson TB; Mascarenhas D; Cohen P
Growth Horm IGF Res; 2003; 13(2-3):89-97. PubMed ID: 12735930
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism.
James PL; Stewart CE; Rotwein P
J Cell Biol; 1996 May; 133(3):683-93. PubMed ID: 8636241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
